Key Insights

Highlights

Treatment Research

3 treatments under study, led by Bledilait Biofer

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Suspended1
Not Yet Recruiting1

Clinical Trials (2)

Showing 2 of 2 trials
NCT07861607Not Yet Recruiting

Reticulocyte Hemoglobin Equivalent (RET-He) in Early Detection of Iron Deficiency Among Blood Donors and Its Potential Impact on Donor Eligibility and Transfusion Safety

NCT00554814Not ApplicableSuspendedPrimary

Interest of Biofer ® Compound Used in Blédilait Follow on Milk in Infant With Latent Iron Deficiency

Showing all 2 trials

Research Network

Common Treatments

  • Bledilait Biofer1
  • Milk Supplemented With Ferrous Sulphate1
  • Blédilait Biofer1

Active Sponsors

  • Bledina1
  • Assiut University1

Top Investigators

Related Conditions

  • Blood Donors1
  • Iron Deficiency Anemia1
  • Iron Deficiency1

Activity Timeline